Vita Life Sciences Financial Health

Short Term Liabilities: VLS's short term assets (A$39.1M) exceed its short term liabilities (A$15.3M).

Long Term Liabilities: VLS's short term assets (A$39.1M) exceed its long term liabilities (A$474.0K).

Debt Level: VLS is debt free.

Reducing Debt: VLS has no debt compared to 5 years ago when its debt to equity ratio was 9.9%.

Debt Coverage: VLS has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: VLS has no debt, therefore coverage of interest payments is not a concern.

• Healthy companies in the Pharmaceuticals & Biotech industry.